ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) is a breast cancer phenotype characterized by an immunohistochemical absence of estrogen receptor (ER) and progesterone receptor (PR), as well as absence of amplification of the human epidermal growth factor receptor 2 (HER2) gene [1].